The predictive value of serum neopterin for multiple organ dysfunction syndrome in severe burn patients

被引:1
作者
Ci, Hai [1 ]
Fu, Yu [3 ]
Tian, Peigang [4 ]
Jiang, Wenping [1 ]
Han, Wei [1 ]
Xiong, Wei [1 ]
Ouyang, Jun [2 ]
机构
[1] Shihezi Univ, Affiliated Hosp 1, Dept Burn & Plast Surg, Shihezi 832000, Peoples R China
[2] Shihezi Univ, Affiliated Hosp 1, Dept Emergency, Shihezi 832000, Peoples R China
[3] Shihezi Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Shihezi 832000, Peoples R China
[4] Shihezi Univ, Affiliated Hosp 1, Dept ICU, Shihezi 832000, Peoples R China
关键词
MODS; neopterin; death risk; diagnosis; serological marker; DISEASE-ACTIVITY; MARKER; LEVEL;
D O I
10.1515/pteridines-2018-0019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Objective To investigate the predictive value of serum neopterin for multiple organ dysfunction syndrome (MODS) in severe burn patients. Methods Seventy-six severe burn patients with burns covering a total body surface area (TBSA) above 70% were included in this study. Of the 76 patients, 29 cases developed MODS (MODS group) and the remaining 47 subjects did not (non-MODS group). From the MODS group, 12 patients died (Death group) and 17 patients survived (Survive group). The serum level of neopterin in the MODS and non-MODS groups were examined by radioimmunoassay on following 1, 3 , 7 , 14 , 21 and 28 post-burn days (PBDs). A receiver operating characteristic (ROC) curve was used to analyse the predictive value of serum neopterin for MODS and death. Results The serum neopterin level in the MODS group was significantly higher than that of non-MODS group between 3 similar to 28 PBDs (p<0.001). However, the serum neopterin levels between the MODS and non-MODS groups following 1 PBD were not statistically significant (p>0.05). The best diagnostic performance of serum neopterin for MODS occurred 14 PBDs with the prediction sensitivity and specificity of 75.86% (56.46%similar to 89.70%) and 85.11% (71.69%similar to 93.80%) respectively. However, serum neopterin levels had no clinical value in predicting the death of MODS patients. The area under the ROC curve (AUC) was 0.72 (0.58 similar to 0.85), 0.81 (0.71 similar to 0.92) and 0.83 (0.72-similar to 0.94) for serum neopterin as biomarker in the prediction of MODS after 3, 7 and 14 PBDs, respectively. The AUCs were 0.50 (0.27 similar to 0.73), 0.53 (0.30 similar to 0.76) and 0.56 (0.33 similar to 0.79) for serum neopterin as biomarker in prediction of death for MODS patients after 3, 7 and 14 PBDs, respectively. Conclusion The persistent and significant increase of serum neopterin level is closely related to the development of MODS in patients with severe bums. Serum neopterin is therefore a promising serological marker for MODS early diagnosis, but has little efficacy in the prediction of the likelihood of death in severe burn patients with MODS.
引用
收藏
页码:196 / 200
页数:5
相关论文
共 22 条
  • [1] Plasma level of neopterin as a marker of disease activity in treated rheumatoid arthritis patients: Association with gender, disease activity and anti-CCP antibody
    Arshadi, Delnia
    Nikbin, Behrouz
    Shakiba, Yadollah
    Kiani, Amir
    Jamshidi, Ahmad Reza
    Boroushaki, Mohammad Taher
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 17 (03) : 763 - 767
  • [2] NEOPTERIN PLASMA-LEVELS IN BURN PATIENTS
    BALOGH, D
    LAMMER, H
    KORNBERGER, E
    STUFFER, M
    SCHONITZER, D
    [J]. BURNS, 1992, 18 (03) : 185 - 188
  • [3] BARROW RE, 1990, SURG GYNECOL OBSTET, V170, P295
  • [4] Chai Jia-ke, 2008, Zhonghua Shao Shang Za Zhi, V24, P378
  • [5] Demirturk N, 2007, HEPATO-GASTROENTEROL, V54, P903
  • [6] Serum level of neopterin is not a marker of disease activity in treated rheumatoid arthritis patients
    El-Lebedy, Dalia
    Hussein, Jihan
    Ashmawy, Ingy
    Mohammed, Asmaa M.
    [J]. CLINICAL RHEUMATOLOGY, 2017, 36 (09) : 1975 - 1979
  • [7] Body Mass Index (BMI) and mortality in patients with severe burns: Is there a "tilt point" at which obesity influences outcome?
    Ghanem, Ali M.
    Sen, Sankhya
    Philp, Bruce
    Dziewulski, Peter
    Shelley, Odhran P.
    [J]. BURNS, 2011, 37 (02) : 208 - 214
  • [8] Neopterin, Inflammation, and Oxidative Stress: What Could We Be Missing?
    Gieseg, Steven P.
    Baxter-Parker, Gregory
    Lindsay, Angus
    [J]. ANTIOXIDANTS, 2018, 7 (07):
  • [9] Serum neopterin levels in patients with replicative and nonreplicative HBV carriers
    Kaleli, Ilknur
    Demir, Melek
    Cevahir, Nural
    Yilmaz, Mustafa
    Demir, Suleyman
    [J]. BMC INFECTIOUS DISEASES, 2006, 6 (1)
  • [10] Kozlowska-Murawska Jolanta, 2008, Wiad Lek, V61, P269